PARP-1 inhibitors (Central South University/Chinese Academy of Sciences)

N/A

Report date: 2025/01/26 15:09:55
NME

Base Information

Drug NamePARP-1 inhibitors (Central South University/Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly (ADP-Ribose) polymerase 1 inhibitors
TargetsPoly (ADP-Ribose) polymerase 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesCentral South University
China Registration ClassN/A

Develop Information

Active CompaniesChinese Academy Of SciencesCentral South University
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A